Effect of the fragrance inhalation of essential oil from Asarum heterotropoides on depression-like behaviors in mice

BMC Complement Altern Med. 2015 Mar 6:15:43. doi: 10.1186/s12906-015-0571-1.

Abstract

Background: Psychological stressors may cause affective disorders, such as depression and anxiety, by altering expressions of corticotropin releasing factor (CRF), serotonin (5-HT), and tyrosine hydroxylase (TH) in the brain. This study investigated the effects of essential oil from Asarum heterotropoides (EOAH) on depression-like behaviors and brain expressions of CRF, 5-HT, and TH in mice challenged with stress.

Methods: Male ICR mice received fragrance inhalation of EOAH (0.25, 0.5, 1.0, and 2.0 g) for 3 h in the special cage capped with a filter paper before start of the forced swimming test (FST) and tail suspension test (TST). The duration of immobility was measured for the determination of depression-like behavior in the FST and TST. The selective serotonin reuptake inhibitor fluoxetine as positive control was administered at a dose of 15 mg/kg (i.p.) 30 min before start of behavioral testing. Immunoreactivities of CRF, 5-HT, and TH in the brain were also measured using separate groups of mice subjected to the FST.

Results: EOAH at higher doses (1.0 and 2.0 g) reduced immobility time in the FST and TST. In addition, EOAH at a dose of 1.0 g significantly reduced the expected increases in the expression of CRF positive neurons in the paraventricular nucleus and the expression of TH positive neurons in the locus coeruleus, and the expected decreases of the 5-HT positive neurons in the dorsal raphe nucleus.

Conclusion: These results provide strong evidence that EOAH effectively inhibits depression-like behavioral responses, brain CRF and TH expression increases, and brain 5-HT expression decreases in mice challenged with stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Anxiety / drug therapy
  • Aromatherapy*
  • Asarum / chemistry*
  • Behavior, Animal
  • Brain / drug effects*
  • Brain / metabolism
  • Corticotropin-Releasing Hormone / metabolism
  • Depression / drug therapy*
  • Depression / etiology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / etiology
  • Hindlimb Suspension
  • Male
  • Mice, Inbred ICR
  • Oils, Volatile / pharmacology
  • Oils, Volatile / therapeutic use*
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Serotonin / metabolism
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / etiology
  • Swimming
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Oils, Volatile
  • Serotonin Uptake Inhibitors
  • Receptor, Serotonin, 5-HT1A
  • Serotonin
  • Corticotropin-Releasing Hormone
  • Tyrosine 3-Monooxygenase